pharmaceutical investing Mersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates
pharmaceutical investing Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura
pharmaceutical investing Stellar Biotechnologies enters exclusive agreement with Amaran Biotechnology
American Uranium Reports Strong Early Infill Drilling Results at its 9.45Mlb Lo Herma ISR Uranium Project in Wyoming's Powder River Basin Ahead of Q3 Resource Upgrade
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
Nevada Sunrise Enters into Earn-in Option Agreement for the Fivemile Gold Project, Cortez Mining District, Nevada
